Novo Nordisk AS (NONOF)
105.00
+2.16
(+2.10%)
USD |
OTCM |
Nov 22, 16:00
Novo Nordisk Price: 105.00 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 103.00 | 106.19 | 101.70 | 105.00 | 5881.00 |
| Nov 21, 2024 | 105.67 | 105.67 | 100.00 | 102.84 | 5907.00 |
| Nov 20, 2024 | 101.28 | 107.00 | 99.65 | 105.49 | 56890.00 |
| Nov 19, 2024 | 98.75 | 105.00 | 98.75 | 101.21 | 9245.00 |
| Nov 18, 2024 | 102.00 | 103.99 | 98.03 | 101.21 | 44915.00 |
| Nov 15, 2024 | 104.23 | 105.00 | 99.37 | 102.20 | 75590.00 |
| Nov 14, 2024 | 110.90 | 110.90 | 104.26 | 105.79 | 66359.00 |
| Nov 13, 2024 | 104.11 | 110.00 | 103.00 | 104.81 | 4914.00 |
| Nov 12, 2024 | 107.99 | 108.84 | 104.57 | 105.43 | 3650.00 |
| Nov 11, 2024 | 113.23 | 113.90 | 107.80 | 107.81 | 18079.00 |
| Nov 08, 2024 | 102.90 | 111.20 | 102.90 | 110.70 | 94142.00 |
| Nov 07, 2024 | 110.00 | 110.25 | 106.00 | 106.01 | 95329.00 |
| Nov 06, 2024 | 104.35 | 112.50 | 104.35 | 110.60 | 4442.00 |
| Nov 05, 2024 | 110.48 | 112.15 | 105.00 | 106.21 | 35284.00 |
| Nov 04, 2024 | 114.55 | 114.55 | 107.79 | 109.80 | 8171.00 |
| Nov 01, 2024 | 115.29 | 115.29 | 109.00 | 111.54 | 2555.00 |
| Oct 31, 2024 | 110.80 | 113.03 | 105.90 | 109.00 | 3986.00 |
| Oct 30, 2024 | 112.70 | 114.00 | 105.98 | 110.80 | 56602.00 |
| Oct 29, 2024 | 115.65 | 115.65 | 109.53 | 110.75 | 109547.0 |
| Oct 28, 2024 | 116.75 | 116.75 | 111.13 | 113.14 | 57347.00 |
| Oct 25, 2024 | 115.20 | 115.20 | 112.00 | 115.20 | 58563.00 |
| Oct 24, 2024 | 115.00 | 117.58 | 112.00 | 116.00 | 2361.00 |
| Oct 23, 2024 | 117.54 | 117.54 | 112.02 | 114.22 | 61888.00 |
| Oct 22, 2024 | 115.05 | 118.50 | 112.90 | 117.00 | 74128.00 |
| Oct 21, 2024 | 120.15 | 120.25 | 115.78 | 119.12 | 2317.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
24.34
Minimum
Mar 23 2020
148.95
Maximum
Jun 25 2024
66.31
Average
54.07
Median
Price Benchmarks
| Eli Lilly and Co | 748.01 |
| Genmab AS | 20.65 |
| Ascendis Pharma AS | 129.81 |
| Galecto Inc | 5.62 |
Price Related Metrics
| PE Ratio | 34.02 |
| PS Ratio | 11.92 |
| PEG Ratio | 1.210 |
| Price to Book Value | 25.84 |
| Price to Free Cash Flow | 47.73 |
| Earnings Yield | 2.94% |
| Market Cap | 466.54B |
| PEGY Ratio | 1.153 |
| Operating PE Ratio | 27.23 |
| Normalized PE Ratio | 34.02 |